VU 0155041

Known as: VU-0155041, VU0155041 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2015
012320082015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
In the present study, we investigated the effect of ACPT-I [(1S, 3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid], a blood… (More)
Is this relevant?
2015
2015
Type 4 metabotropic glutamate (mGlu4) receptors are emerging targets for the treatment of various disorders. Accordingly… (More)
Is this relevant?
2014
2014
The present study investigated the role of metabotropic glutamate receptor subtype 8 (mGluR8) in the dorsal striatum (DS) in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Group III metabotropic glutamate receptors (mGluR4,7,8) are widely distributed in the basal ganglia. Injection of group III mGluR… (More)
Is this relevant?
2012
2012
The present study was designed to evaluate the possible neuroprotective effects of metabotropic glutamate receptor (mGluR7… (More)
Is this relevant?
2012
2012
BACKGROUND AND PURPOSE We recently reported that broad spectrum agonist-induced activation of presynaptic group III metabotropic… (More)
Is this relevant?
2012
2012
Glutamate, the major excitatory neurotransmitter in the retina, functions by activation of both ionotropic (iGluR) and… (More)
Is this relevant?
2011
2011
Glutamate receptors (GluRs) play a critical role in pain pathway. Recent studies have shown that activation of spinal group III… (More)
Is this relevant?
2011
2011
Expression of group III metabotropic glutamate receptors (mGluR) was established by RT-PCR and immunocytochemistry on a cultured… (More)
Is this relevant?
2008
2008
Parkinson's disease (PD) is caused by the death of dopamine neurons in the basal ganglia and results in motor symptoms such as… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?